Cover Image
市場調查報告書

全球性感染疾病(STD)檢驗市場

Global Sexually Transmitted Disease (STD) Testing Market 2014-2018

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 317317
出版日期 內容資訊 英文 85 Pages
訂單完成後即時交付
價格
Back to Top
全球性感染疾病(STD)檢驗市場 Global Sexually Transmitted Disease (STD) Testing Market 2014-2018
出版日期: 2014年10月22日 內容資訊: 英文 85 Pages
簡介

性感染疾病(STD)近幾年擴大了,全球STD檢驗市場預計從2013年到2018年5年,以5.64%的年複合成長率(CAGR)持續擴大。

本報告以全球STD檢驗市場為主題,提供由許多產業專家取得的資料、資訊,以及推動市場成長要素、市場課題、市場趨勢,及市場競爭情形詳細分析為基礎之市場規模估計與未來的成長預測。

第1章 摘要整理

第2章 簡稱表

第3章 本報告涵蓋範圍

  • 市場概要
  • 提供產品

第4章 市場調查手法

  • 市場調查流程
  • 調查手法

第5章 市場情形

  • 市場概要
  • 市場規模及未來預測

第6章 序論

  • 波特的五力分析

第7章 各用途市場分析

  • 披衣菌感染檢驗全球市場
    • 市場規模及未來預測
  • 淋病檢驗全球市場
    • 市場規模及未來預測
  • 梅毒檢驗全球市場
    • 市場規模及未來預測
  • HIV檢驗全球市場
    • 市場規模及未來預測
  • HSV (單純皰疹病毒)檢驗全球市場
    • 市場規模及未來預測
  • HPV (人類乳突病毒)檢驗全球市場
    • 市場規模及未來預測
  • 軟性下疳檢驗全球市場
    • 市場規模及未來預測

第8章 各終端用戶市場分析

  • 檢驗中心的STD檢驗全球市場
    • 市場規模及未來預測
  • 體檢室的STD檢驗全球市場
    • 市場規模及未來預測

第9章 各地區市場分析

  • 南北美洲的STD檢驗市場
    • 市場規模及未來預測
  • 歐洲、中東,及非洲地區的STD檢驗市場
    • 市場規模及未來預測
  • 亞太地區的STD檢驗市場
    • 市場規模及未來預測

第10章 購買標準

第11章 推動市場成長要素

第12章 推動市場成長要素與其影響

第13章 市場課題

第14章 市場成長促進要素和市場課題帶來的影響

第15章 市場趨勢

第16章 市場趨勢與其影響

第17章 供應商情形

  • 市場競爭方案
    • 重要新聞
    • 企業M&A
  • 市場佔有率分析
  • 其他重要供應商

第18章 主要供應商分析

  • Alere
  • Becton, Dickinson and Co.
  • bioMeriux
  • Roche Diagnostics

第19章 相關報告

附表、附圖

目錄
Product Code: IRTNTR4524

Sexually transmitted diseases (STDs) can be caused by infections that are passed from one person to another person through sexual contact. It can also be transmitted through nonsexual modes such as from mother to infant during pregnancy, childbirth, blood transfusions, and through shared needles. People are sexually active at a younger age and involve in multiple partners relationship because of which STDs have become more common in recent years. In addition, people can pass STDs to their sexual partners without any symptoms to themselves.

TechNavio's analysts forecast the Global Sexually Transmitted Disease Testing market to grow at a CAGR of 5.64 percent over the period 2013-2018.

Covered in this Report

The Global Sexually Transmitted Disease Testing market can be segmented based on the revenue generated from various applications such as chlamydia testing, gonorrhea testing, syphilis testing, HIV testing, HSV testing, HPV testing, and chancroid testing.

TechNavio's report, Global Sexually Transmitted Disease Testing Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the APAC and EMEA regions; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Alere
  • Becton Dickinson and Company
  • bioMerieux
  • F. Hoffmann-La Roche

Other Prominent Vendors

  • Abbott
  • Bio-Rad
  • Cepheid
  • DiaSorin
  • Erba Diagnostics
  • Grifols
  • Hologic Gen-Probe
  • Hospitex Diagnostics
  • Siemens Healthcare
  • Qiagen

Market Driver

  • Growing Incidence of STDs in Adolescents and Young Adults
  • For a full, detailed list, view our report

Market Challenge

  • Accurate Diagnostics Testing
  • For a full, detailed list, view our report

Market Trend

  • Ready-to-use Reagents
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be
  • What are the key market trends
  • What is driving this market
  • What are the challenges to market growth
  • Who are the key vendors in this market space
  • What are the market opportunities and threats faced by the key vendors
  • What are the strengths and weaknesses of the key vendors

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Market Landscape

  • 05.1. Market Overview
  • 05.2. Market Size and Forecast

06. Introduction

  • 06.1. Five Forces Analysis

07. Market Segmentation by Application

  • 07.1. Global Chlamydia Testing Market
    • 07.1.1. Market Size and Forecast
  • 07.2. Global Gonorrhea Testing Market
    • 07.2.1. Market Size and Forecast
  • 07.3. Global Syphilis Testing Market
    • 07.3.1. Market Size and Forecast
  • 07.4. Global HIV Testing Market
    • 07.4.1. Market Size and Forecast
  • 07.5. Global HSV Testing Market
    • 07.5.1. Market Size and Forecast
  • 07.6. Global HPV Testing Market
    • 07.6.1. Market Size and Forecast
  • 07.7. Global Chancroid Testing Market
    • 07.7.1. Market Size and Forecast

08. Market Segmentation by End-users

  • 08.1. Global STD Laboratory Testing Market
    • 08.1.1. Market Size and Forecast
  • 08.2. Global STD Point-of-Care Testing Market
    • 08.2.1. Market Size and Forecast

09. Geographical Segmentation

  • 09.1. STD Testing Market in the Americas
    • 09.1.1. Market Size and Forecast
  • 09.2. STD Testing Market in the EMEA Region
    • 09.2.1. Market Size and Forecast
  • 09.3. STD Testing Market in the APAC Region
    • 09.3.1. Market Size and Forecast

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape

  • 17.1. Competitive Scenario
    • 17.1.1. Key News
    • 17.1.2. Mergers and Acquisitions
  • 17.2. Market Share Analysis 2013
  • 17.3. Other Prominent Vendors

18. Key Vendor Analysis

  • 18.1. Alere
    • 18.1.1. Key Facts
    • 18.1.2. Business Overview
    • 18.1.3. Business Segmentation by Revenue 2013
    • 18.1.4. Business Segmentation by Revenue 2012 and 2013
    • 18.1.5. Geographical Segmentation by Revenue 2013
    • 18.1.6. Business Strategy
    • 18.1.7. Recent Developments
    • 18.1.8. SWOT Analysis
  • 18.2. Becton, Dickinson and Co.
    • 18.2.1. Key Facts
    • 18.2.2. Business Description
    • 18.2.3. Business Segmentation
    • 18.2.4. Revenue Segmentation by Business
    • 18.2.5. Segmental Revenue Comparison - 2013 and 2012
    • 18.2.6. Revenue Segmentation by Geography
    • 18.2.7. Business Strategy
    • 18.2.8. Key Developments
    • 18.2.9. SWOT Analysis
    • 18.2.10. SWOT Overview
  • 18.3. bioMeriux
    • 18.3.1. Key Facts
    • 18.3.2. Business Overview
    • 18.3.3. Business Segmentation by Revenue 2013
    • 18.3.4. Geographical Segmentation by Revenue 2013
    • 18.3.5. Business Strategy
    • 18.3.6. Recent Developments
    • 18.3.7. SWOT Analysis
  • 18.4. Roche Diagnostics
    • 18.4.1. Key Facts
    • 18.4.2. Business Overview
    • 18.4.3. Business Segmentation by Revenue 2013
    • 18.4.4. Geographical Segmentation by Revenue 2013
    • 18.4.5. Business Strategy
    • 18.4.6. Recent Developments
    • 18.4.7. SWOT Analysis

19. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Segmentation of Global STD Testing Market
  • Exhibit 2: Market Research Methodology
  • Exhibit 3: Global STD Testing Market 2013-2018 (US$ billion)
  • Exhibit 4: Global STD Testing Market Segmentation by Application
  • Exhibit 5: The Application and Limitations of Diagnostic Tests in Different Stages of Syphilis
  • Exhibit 6: Socioeconomic Factors Affecting HIV Risks
  • Exhibit 7: Types of HPV testing
  • Exhibit 8: Clinical Manifestations Associated with HPV
  • Exhibit 9: Diagnostics Tests for Chancroid
  • Exhibit 10: Global STD Testing Market Segmentation by Application 2013
  • Exhibit 11: Global Chlamydia Testing Market 2013-2018 (US$ billion)
  • Exhibit 12: Global Gonorrhea Testing Market 2013-2018 (US$ billion)
  • Exhibit 13: Global Syphilis Testing Market 2013-2018 (US$ billion)
  • Exhibit 14: Estimated Number of Adverse Outcomes Associated With Syphilis In Pregnancy in Worst, Middle, and Best Case Scenarios of Testing and Treatment Coverage In 2008
  • Exhibit 15: Global HIV Testing Market 2013-2018 (US$ billion)
  • Exhibit 16: amfAR Regional Estimation of HIV/AIDS
  • Exhibit 17: Global HSV Testing Market 2013-2018 (US$ billion)
  • Exhibit 18: Global HPV Testing Market 2013-2018 (US$ billion)
  • Exhibit 19: Global Chancroid Testing Market 2013-2018 (US$ billion)
  • Exhibit 20: Global STD Testing Market Segmentation by Application 2013-2018
  • Exhibit 21: Global STD Testing Market Segmentation by Application 2013-2018 (US$ billion)
  • Exhibit 22: Global STD Testing Market Segmentation by End-user
  • Exhibit 23: Global STD Testing Market Segmentation by End-user 2013
  • Exhibit 24: Global STD Laboratory Testing Market 2013-2018 (US$ billion)
  • Exhibit 25: Global STD Point-of-Care Testing Market 2013-2018 (US$ billion)
  • Exhibit 26: Global STD Testing Market Segmentation by End-users 2013-2018
  • Exhibit 27: Global STD Testing Market Segmentation by End-users 2013-2018 (US$ billion)
  • Exhibit 28: Global STD Testing Market by Geographical Segmentation 2013
  • Exhibit 29: STD Testing Market in the Americas 2013-2018 (US$ billion)
  • Exhibit 30: STD Testing Market in the EMEA Region 2013-2018 (US$ billion)
  • Exhibit 31: STD Testing Market in the APAC Region 2013-2018 (US$ billion)
  • Exhibit 32: Global STD Testing Market by Geographical Segmentation 2013-2018
  • Exhibit 33: Global STD Testing Market by Geographical Segmentation 2013-2018 (US$ billion)
  • Exhibit 34: Chlamydia and Gonorrhea rates (per 100,000) Ages 15-19, By Gender, 2011
  • Exhibit 35: Alere: Business Segmentation by Revenue 2013
  • Exhibit 36: Alere: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 37: Alere: Geographical Segmentation by Revenue 2013
  • Exhibit 38: Product Categorization of Becton, Dickinson and Co.
  • Exhibit 39: Revenue Segmentation of Becton, Dickinson and Co. 2013
  • Exhibit 40: Revenue Comparison (US$ million)
  • Exhibit 41: Revenue Segmentation of Becton, Dickinson and Co. by Geography 2013
  • Exhibit 42: bioMeriux: Business Segmentation by Revenue 2013
  • Exhibit 43: bioMeriux: Geographical Segmentation by Revenue 2013
  • Exhibit 44: Roche Diagnostics: Business Segmentation by Revenue 2013
  • Exhibit 45: Roche Diagnostics: Geographical Segmentation by Revenue 2013
Back to Top